poisar

Stocks · News reference

8-K filing — Aclaris Therapeutics, Inc. (ACRS)

SEC EDGARSEC EDGAR

Filed: 2026-08-06 AccNo: 0001104659-26-092128 Size: 473 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    Aclaris Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

    Aclaris Therapeutics announced that CEO Dr. Neal Walker will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on September 10, 2026. The clinical-stage biopharmaceutical company, which focuses on developing treatments for immuno-inflammatory diseases, will provide a live and archived webcast of the event on its website.